i4i Product Development Awards (PDA) support translational research and development of medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies for ultimate NHS use.
The research proposals may address any disease or health area, provided there is a clear unmet clinical need. There is no upper funding limit for Product Development Awards, but costs must be fully justified.
For all i4i awards the lead organisation must be based in England. The lead organisation may be any of the types of eligible organisation listed below. The following types of organisations are eligible for funding:
A collaboration of two or more of the above is eligible. Applications which involve partnerships between a university and its associated NHS Trust are considered eligible collaborations. If support for a clinical trial is requested, one of the partners must be an NHS organisation or other NHS service provider which has agreed to be the sponsor of the trial.
It is possible that an organisation outside England can request funding as a co-applicant, if an appropriate case is made.
Specialist services or expertise may be brought into the team through consultancy or sub-contract arrangements, however, appropriate justification must be provided. Sub-contractors may be based outside of England.
Funded activities include the following:
The i4i programme will not fund: